Showing results out of
A new research paper published in Nature Communications lays the groundwork for the development of new drugs specific to genetic mutations or alterations responsible for the onset of tumours or genetic diseases.
SCIENCE & TECHNOLOGY2024
science-technology
The memorandum of understanding (MoU) signed between EMBL and the Institute for Advanced Biosciences (IAB) a year ago has already catalysed new grants for joint research projects related to cancer and infection biology, thereby deepening collaborative activities.
CONNECTIONSLAB MATTERS2021
connectionslab-matters
While global research on coronaviruses has shed light on the function of many SARS-CoV-2 proteins, the role of some crucial components remains unknown. Researchers at EMBL Grenoble will use a range of structural biology methods to try to solve some of the puzzles of the molecular mechanics of…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Researchers in the Marcia group at EMBL Grenoble and the De Vivo lab at the Italian Institute of Technology in Genoa have obtained some of the most detailed ever snapshots of the splicing process in systems known as group II self-splicing introns. The new insights will help scientists to develop…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
MEG3 adopts a complex three-dimensional structure to fulfil its tumour suppressor function.
SCIENCE & TECHNOLOGY2019
sciencescience-technology
EMBL scientists superimpose structures of two-metal-ion enzymes and reveal new potential drug targets
SCIENCE & TECHNOLOGY2017
sciencescience-technology
New group leader Marco Marcia aims to broaden horizons while mapping molecules.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
No results found